Isis Pharmaceuticals, Inc. (ISIS) Tops Q4 EPS by 20c
Tweet Send to a FriendGet Alerts ISIS Hot Sheet
Price: $20.85 +2.26%
EPS Growth %: +91.7%
Financial Fact:
Equity in net loss of Regulus Therapeutics Inc.: 0
Today's EPS Names:
BOSC, GASS, AAP, More
EPS Growth %: +91.7%
Financial Fact:
Equity in net loss of Regulus Therapeutics Inc.: 0
Today's EPS Names:
BOSC, GASS, AAP, More
Trade ISIS Now!
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) reported Q4 EPS of ($0.03), $0.20 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $19.9 million versus the consensus estimate of $15.78 million.
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Isis Pharmaceuticals, Inc. (ISIS) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- GameStop Corp. (GME) Tops Q1 EPS by 6c; Boosts Lower-End of FY13 EPS Outlook
- Taomee Holdings Ltd. (TAOM) Misses Q1 EPS by 2c; Guides Q2 Sales
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
